Polpharma Biologics na CEBioForum 2024

CEBioForum 2024 is an annual international conference for the biotechnology sector and also the largest industry event in Poland. Polpharma Biologics also attended this year's edition (26-27 March), among a strong representation of panellists, exhibitors and participants!

Polpharma Biologics representatives Adriana Kiędzierska-Mencfeld (Chief Integration Officer) and Alex Moulson (Chief Strategy & Portfolio Officer) took part in panel discussions.

Adriana Kiędzierska-Mencfeld tried to reply to the important question of "How to handle biomanufacturing?" during a panel discussion under the same title. Adriana shared her knowledge and extensive experience in the field of biomanufacturing:

"Developing biosimilars is a very expensive and time-consuming process. A company's market advantage will be determined by their ability to deliver product to the market with the proper COGS, reflecting price erosion. We can achieve this through process intensification. We should bear in mind, when talking about a company's market advantage, this also includes driving availability of a particular biological drug for patients. There is more than efficiency to this, this is the core of our activities”.

Alex Moulson participated in the “5 steps of commercialisation” panel, where industry experts shared insights on technology transfer, scaling production and building robust business models for pharmaceutical solutions.

Polpharma Biologics also operated a dedicated stand at the event, attracting numerous enthusiastic young minds. Our company stand was hosted by Alicja Kryczało-Lara (Head of Talent Attraction), Anna Zamojska-Jaroszewicz (Drug Substance Manufacturing Director) and Michał Michalik (Head of DSP), who promoted the Polpharma Biologics brand together during discussions with potential talent for our production team in Duchnice. 

The forum was also attended by Piotr Korycki (President of the Management Board PB SA), Jowita Kacik (Head of Communications) and Maciej Szerszenowicz (Engineering Director), who held numerous discussions with participants throughout the conference, covering both topics related to the conference topics, as well as inspiring motivation.

We would like to thank everyone who joined us during this event. Your participation made it a truly remarkable experience. It was hugely satisfying to hear that our practical approach and the extensive knowledge shared by our panellists resonated with the participants. We are already seeing ideas for the CEBioForum 2025 pop up in our heads!